N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride

C29H44ClN7O — CID 71652179

IUPACN-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride
SMILESCCCCCc1ccc(C(=O)NCCn2cc(CCCCCc3cn(C4CCCC4)c(N)n3)nn2)cc1.Cl
InChIInChI=1S/C29H43N7O.ClH/c1-2-3-5-10-23-15-17-24(18-16-23)28(37)31-19-20-35-21-26(33-34-35)12-7-4-6-11-25-22-36(29(30)32-25)27-13-8-9-14-27;/h15-18,21-22,27H,2-14,19-20H2,1H3,(H2,30,32)(H,31,37);1H
InChIKeyULRCSXNIMCPDMZ-UHFFFAOYSA-N
MW542.17 g/mol
LogP5.71
Rot. Bonds15

About N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride

N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride (PubChem CID 71652179) has the molecular formula C29H44ClN7O and a molecular weight of 542.17 g/mol. Its IUPAC name is N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride.

Molecular Properties

Compound NameN-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride
PubChem CID71652179
Molecular FormulaC29H44ClN7O
Molecular Weight542.17 g/mol
Exact Mass541.33
IUPAC NameN-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride
SMILESCCCCCc1ccc(C(=O)NCCn2cc(CCCCCc3cn(C4CCCC4)c(N)n3)nn2)cc1.Cl
InChIInChI=1S/C29H43N7O.ClH/c1-2-3-5-10-23-15-17-24(18-16-23)28(37)31-19-20-35-21-26(33-34-35)12-7-4-6-11-25-22-36(29(30)32-25)27-13-8-9-14-27;/h15-18,21-22,27H,2-14,19-20H2,1H3,(H2,30,32)(H,31,37);1H
InChIKeyULRCSXNIMCPDMZ-UHFFFAOYSA-N
XLogP5.71
TPSA103.65 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds15
Heavy Atoms38
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500542.17
LogP ≤ 55.71
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride?
The IUPAC name of N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride (CID 71652179) is N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride.
What is the SMILES notation for N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride?
The canonical SMILES for N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride is CCCCCc1ccc(C(=O)NCCn2cc(CCCCCc3cn(C4CCCC4)c(N)n3)nn2)cc1.Cl.
What is the InChIKey of N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride?
The InChIKey is ULRCSXNIMCPDMZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H43N7O.ClH/c1-2-3-5-10-23-15-17-24(18-16-23)28(37)31-19-20-35-21-26(33-34-35)12-7-4-6-11-25-22-36(29(30)32-25)27-13-8-9-14-27;/h15-18,21-22,27H,2-14,19-20H2,1H3,(H2,30,32)(H,31,37);1H.
What are the key properties of N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride?
N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride has a molecular weight of 542.17 g/mol, XLogP of 5.71, 15 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[5-(2-amino-1-cyclopentylimidazol-4-yl)pentyl]triazol-1-yl]ethyl]-4-pentylbenzamide;hydrochloride is sourced from PubChem (CID 71652179), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).